Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
3.670
+0.050 (1.38%)
At close: Dec 18, 2025, 4:00 PM EST
3.650
-0.020 (-0.54%)
After-hours: Dec 18, 2025, 7:24 PM EST
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $97.27 million as of December 18, 2025. Its market cap has decreased by -3.16% in one year.
Market Cap
97.27M
Enterprise Value
82.24M
1-Year Change
-3.16%
Ranking
Category
Stock Price
$3.67
Market Cap Chart
Since January 29, 2020, Annovis Bio's market cap has increased from $62.51M to $97.27M, an increase of 55.60%. That is a compound annual growth rate of 7.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 17, 2025 | 95.94M | 38.24% |
| Dec 31, 2024 | 69.40M | -63.84% |
| Dec 29, 2023 | 191.90M | 75.03% |
| Dec 30, 2022 | 109.64M | -23.01% |
| Dec 31, 2021 | 142.41M | 174.06% |
| Dec 31, 2020 | 51.96M | -16.87% |
| Jan 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.80B |
| Johnson & Johnson | 506.75B |
| AbbVie | 396.44B |
| UnitedHealth Group | 300.40B |
| AstraZeneca | 281.50B |
| Novartis AG | 260.63B |
| Merck & Co. | 246.17B |
| Abbott Laboratories | 220.33B |